Literature DB >> 6231307

Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

C Morimoto, E L Reinherz, J A Distaso, A D Steinberg, S F Schlossman.   

Abstract

Previous studies have shown that patients with systemic lupus erythematosus (SLE) had differing T cell T4+/T8+ ratios and that the ratio correlated with clinical features of the disease. In the present study, we wished to determine whether the peripheral blood T cell subsets in these patients were related to the specificity of anti-T cell antibodies found in their plasma. Plasma from 24 SLE patients that reacted with greater than 20% of normal T cells were analyzed for their effect on in vitro pokeweed mitogen-stimulated immunoglobulin synthesis and for their reactivity with human T4+ and T8+ cells. Anti-T cell antibodies found in SLE patients have a spectrum of reactivities. We concentrated upon antibodies that interfere with suppressor function. One group of SLE anti-T cell antibodies reacts preferentially with the T8+ suppressor effector cell whereas another is reactive with T4+ suppressor inducer subsets. SLE patients with high T4+/T8+ ratios had anti-T cell antibodies predominantly reactive with the T8+ suppressor effector cells. Patients with low T4+/T8+ ratios, on the other hand, had anti-T cell antibodies reactive with either the T4+ suppressor inducer or with both the T4+ suppressor inducer and T8+ suppressor effector cells. In addition, a fourth group was defined whose anti-T cell antibodies were neither reactive with a functional T4+ suppressor inducer nor a functional T8+ suppressor effector cells. There was a significant correlation between the circulating T4+/T8+ ratio of peripheral T cells in these patients and the relative ability of their anti-T cell antibodies to kill T8+ cells vs. T4+ cells (gamma = 0.666, P less than 0.001). These results support the notion that in SLE different cellular defects in the immunoregulatory circuit underlie the development of autoimmune reactions and that the anti-T cell antibodies may cause numerical and functional deficiencies in T cell subsets.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231307      PMCID: PMC425070          DOI: 10.1172/JCI111261

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus.

Authors:  R B Lies; R P Messner; R C Williams
Journal:  Arthritis Rheum       Date:  1973 May-Jun

2.  B cell and T cell lymphopenia in systemic lupus erythematosus.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Cell Immunol       Date:  1974-05       Impact factor: 4.868

3.  Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.

Authors:  N Suciu-Foca; J A Buda; T Thiem; K Reemtsma
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

4.  Abnormalities of delayed hypersensitivity in systemic lupus erythematosus.

Authors:  B H Hahn; K K Bagby; C K Osterland
Journal:  Am J Med       Date:  1973-07       Impact factor: 4.965

5.  Impaired delayed hypersensitivity in systemic lupus erythematosus.

Authors:  D A Horwitz
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

6.  Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity.

Authors:  C J Rosenthal; E C Franklin
Journal:  Arthritis Rheum       Date:  1975 May-Jun

7.  Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.

Authors:  P Stastny; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

8.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; S M Fu; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Lymphocyte subpopulations.

Authors:  R J Powell; J S Jenkins
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

Review 2.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus.

Authors:  S Minota; S Koyasu; I Yahara; J Winfield
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes.

Authors:  J A Charlesworth; P Peake; L V Campbell; J Rumma; B A Pussell; N Howard; G J Elder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

6.  Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitro.

Authors:  P W Peake; J D Greenstein; V Timmermans; L Gavrilovic; J A Charlesworth
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

Review 7.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

8.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 9.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

Review 10.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.